Carbamazepine effect in trigeminal neuragia

The camparison of therapeutic effect of carbamazepine and combination therapy with gabapentin and baclofen, in the treatment of trigeminal neuralgia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202219103N1

Enrollment

Registered

2012-03-25

Start date

2012-01-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trigeminal neuralgia. Syndrome of paroxysmal facial pain Tic douloureux

Interventions

Intervention 1: 200 mg carbamazepine/oral/ 3 times daily / 4 mounths. Intervention 2: 100 mg gabapentin+ 10 mg baclofen / oral/ 3 times dailyl 4 mounths.

Treatment - Drugs

200 mg carbamazepine/oral/ 3 times daily / 4 mounths

100 mg gabapentin+ 10 mg baclofen / oral/ 3 times dailyl 4 mounths

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with trigeminal neuralgia Exclusion criteria: Patients with trigeminal neuralgia and other systemic diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical functional score. Timepoint: 1 week, 3 weak, 2 mounth, 3 mounth, 4 mounth. Method of measurement: 1) same pain 2) tingling and shocking pain 3)tingling 4)complete resolve.;Pain intensity changes. Timepoint: 1 week, 3 weak, 2 mounth, 3 mounth, 4 mounth. Method of measurement: vas.	—

Secondary

Measure	Time frame
Drug side effects. Timepoint: 3 weeks. Method of measurement: Laboratory tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Gholami

Yazd Shadid Sadoughi University of Medical Science, Dental School

nedagholami64@gmail.com+98 35 1621 2222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026